We are live on
!
Find out more
ACMC
AyurMaya Capital Management Company Portfolio holdings
AUM
$148M
1-Year Est. Return
24.4%
This Fund
S&P 500
This Quarter
Est. Return
-51.14%
1 Year Est. Return
+24.4%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$45.4M
AUM Growth
-$43M
(-49%)
Cap. Flow
-$1.83M
Cap. Flow
% of AUM
-4.04%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
1
Reduced
–
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALMS
Alumis Inc
ALMS
|
+$21.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLRN
ACELYRIN
SLRN
|
+$23.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
CFO
D
SA
USWG
LAMNM
CC
MCM
CNFG
AyurMaya Capital Management Company's Q2 2025 Portfolio in Review
As of Q2 2025, AyurMaya Capital Management Company held 2 positions worth $45.4M, down 49% from $88.4M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
AyurMaya Capital Management Company withdrew a net $1.83M in Q2 2025, closing 1 position. Its most notable exit was ACELYRIN, an estimated $23.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
Against the trend, AyurMaya Capital Management Company added an estimated $21.2M to Alumis Inc.
- AyurMaya Capital Management Company added most to Alumis Inc in Q2 2025, an estimated $21.2M increase.
- AyurMaya Capital Management Company fully exited ACELYRIN in Q2 2025, selling an estimated $23.1M.
- AyurMaya Capital Management Company's ten largest holdings make up 100% of its $45.4M portfolio in Q2 2025.
- AyurMaya Capital Management Company opened 0 new positions and closed 1 in Q2 2025.
- AyurMaya Capital Management Company's portfolio value fell 49% quarter-over-quarter to $45.4M.
Based on AyurMaya Capital Management Company's 13F filing for Q2 2025, filed 14 Aug 2025.